JCO Oncology Practice @JCOOP_ASCO · 28 Aug 2026
Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma. Read the full article. https://t.co/3AuIVO5xuu
684Views
3Likes
0Reposts
0Replies
0Quotes
4Bookmarks
Is that a lot?
1.34×vs this author's median509 views is typical
80Percentile for this authorof 5 recent posts
0.21×vs 10K–100K median3 259 views is typical
4.52%Reachviews ÷ followers
0.44%Engagement rateof viewers reacted